期刊文献+

子宫内膜癌的激素治疗进展 被引量:6

暂未订购
导出
摘要 子宫内膜癌是指原发于子宫内膜的一组上皮性恶性肿瘤,近年发病率呈逐渐上升的趋势,40岁以下的患者逐年增加。早期子宫内膜癌以手术治疗为主,晚期、复发或伴有高危因素以及年轻要求保留生育能力的患者,激素治疗是有效的手段。目前关于激素治疗子宫内膜癌的作用途径有不同的分子假说。近年随着对激素治疗子宫内膜癌机制的广泛关注与研究,激素治疗的临床应用取得了很大的进展。但是,由于临床应用时间较短,缺乏大量临床资料,激素治疗子宫内膜癌的疗效、预后、药物剂量、用药时间、给药途径及联合用药等问题仍有待于进一步研究。
作者 徐虹 宋磊
出处 《现代妇产科进展》 CSCD 北大核心 2007年第1期62-64,共3页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献22

  • 1Rose PG.Medical progress:endometrial carcinoma[J].N Engl J Med,1996,335:640-648
  • 2Thighpen T,Bradjy MF,Alvarez RD,et al.Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma:a doseresponse study by the Gynecologic Oncology Group study[J].J Clin Oncol,1999,17:1736-1744
  • 3Thigpen JT,Brady MF,Awarez RD,et al.Oral medroxyprogester-one acetate in the treatment of advanced or recurrent endometrial carcinoma:a dose-reponse study by the Gynecologic Oncology Group[J].J Clin Oncol,1999,17:1736-1744
  • 4Pinelli DM,Fiorica JV,Roberts WS,et al.Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma:a phase II study[J].Gynecol Oncol,1996,60:462-467
  • 5Thighpen T,Bradjy MF,Homsley HD,et al.Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma:a Gynecologic Oncology Group study[J].J Clin Oncol,2001,19:364-367
  • 6McMeekin DS,Gorden A,Fowler J,et al.A phase Ⅱ trial of arzoxifene,a selective receptor modulator,in patients with recurrent or advanced endometrial cancer[J].Gynecol Oncol,2003,90:64-69
  • 7Fiorica JV,Brunetto VL,Hanjani P,et al.Phase Ⅱ trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma:a Gynecologic Oncology Group study[J].Gynecol Oncol,2004,92:10-14
  • 8Whitney CW,Brunetto VL,Zaino RJ,et al.Phase Ⅱ study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma:a Gynecologic Oncology Group study[J].Gynecol Oncol,2004,92:4-9
  • 9Lhomme C,Callet VN,Lesimple T,et al.A multicenter phase Ⅱ study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma:a French Anticancer Federation study[J].Gynecol Oncol,1999,75:187-193
  • 10Ma BB,Oza A,Eisenhauer E,et al.The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers-a study of the National Cancer Institute of Canada Clinical Trials Group[J].Int J Gynecol Cancer,2004,14:650-658

同被引文献53

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部